ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
Society of Benign Prostate Disease 2024 Annual Meeting
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 277130" data-attributes="member: 13851"><p>[MEDIA=youtube]h_IERWjj1yE[/MEDIA]</p><p></p><p></p><p><em>I was recently honored to be a guest speaker among the <strong>innovators, stakeholders, and pioneering minds in managing benign prostate hyperplasia</strong> at the annual assembly of the Society of Benign Prostate Disease, held in Dallas this February. </em></p><p><em></em></p><p><em>Today, I am delighted to have one of the <strong>Society of Benign Prostate Disease board of directors, Dr. Kevin Zorn,</strong> joining me to share an insider perspective as we <strong>review the key takeaways from the meeting and bring you up to speed on the latest technologies for evaluating and managing BPH. We will also offer a sneak peek into several new advancements coming down the pipeline. </strong></em></p><p><em></em></p><p><em>Dr. Kevin Zorn, from the BPH Canada Clinic in Montreal, is a board-certified urologist and former Associate Professor of Urology at the Universities of Montreal and Chicago, <strong>sub-specializing in robotic surgery and BPH surgical care. Throughout his career, Dr. Zorn has been committed to research and innovation. <u>He was the first in Canada and Quebec to use many new BPH technologies, including Greenlight XPS, Rezum, ITind, Optilume, and Aquablation</u>. </strong></em></p><p><em><strong></strong></em></p><p><em><strong>Dr. Zorn is a senior author of the BPH guidelines for the Canadian Urological Association, having authored 345 peer-reviewed publications and 12 book chapters on BPH and minimally invasive surgical care. He has lectured, taught, and practiced surgery globally and is intimately involved in developing several new pioneering BPH technologies. </strong></em></p><p><em><strong></strong></em></p><p><em><strong>Stay tuned for the latest insights and breakthroughs as we unveil the future of BPH management.</strong></em></p></blockquote><p></p>
[QUOTE="madman, post: 277130, member: 13851"] [MEDIA=youtube]h_IERWjj1yE[/MEDIA] [I]I was recently honored to be a guest speaker among the [B]innovators, stakeholders, and pioneering minds in managing benign prostate hyperplasia[/B] at the annual assembly of the Society of Benign Prostate Disease, held in Dallas this February. Today, I am delighted to have one of the [B]Society of Benign Prostate Disease board of directors, Dr. Kevin Zorn,[/B] joining me to share an insider perspective as we [B]review the key takeaways from the meeting and bring you up to speed on the latest technologies for evaluating and managing BPH. We will also offer a sneak peek into several new advancements coming down the pipeline. [/B] Dr. Kevin Zorn, from the BPH Canada Clinic in Montreal, is a board-certified urologist and former Associate Professor of Urology at the Universities of Montreal and Chicago, [B]sub-specializing in robotic surgery and BPH surgical care. Throughout his career, Dr. Zorn has been committed to research and innovation. [U]He was the first in Canada and Quebec to use many new BPH technologies, including Greenlight XPS, Rezum, ITind, Optilume, and Aquablation[/U]. Dr. Zorn is a senior author of the BPH guidelines for the Canadian Urological Association, having authored 345 peer-reviewed publications and 12 book chapters on BPH and minimally invasive surgical care. He has lectured, taught, and practiced surgery globally and is intimately involved in developing several new pioneering BPH technologies. Stay tuned for the latest insights and breakthroughs as we unveil the future of BPH management.[/B][/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
Society of Benign Prostate Disease 2024 Annual Meeting
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top